Francesca Barone serves as Executive at Candel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Francesca Barone has executed 6 insider transactions totaling $168.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 17, 2024 involved selling 14,051 shares valued at $90.9K.
Francesca Barone currently holds 159,961 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Francesca Barone has been a net seller of CADL stock. They have purchased $2.0K and sold $166.4K worth of shares.
Francesca Barone's most recent insider trade was on Jul 17, 2024, when they sold 14,051 shares at $6.47 per share.
Get notified when new Form 4 filings are submitted
| $5.97 |
| Discretionary |
| Nov 28, 2023 | CADL | $17.8K | Payment | 19,748 | $0.90 | Discretionary |
| Nov 26, 2023 | CADL | $0 | Award | 112,790 | $N/A | Discretionary |
| Dec 8, 2022 | CADL | $2.0K | Purchase | 1,238 | $1.61 | Discretionary |
| Nov 28, 2022 | CADL | $0 | Award | 90,877 | $N/A | Discretionary |